Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months – Multicenter European cohort study-Reference-Cited by-同舟云学术

Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months – Multicenter European cohort study

Published:2016-06 Issue:6 Volume:48 Page:592-600
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Van Assche Gert^ORCID,Peyrin-Biroulet Laurent,Sturm Andreas,Gisbert Javier P.,Gaya Daniel R.,Bokemeyer Bern,Mantzaris Gerassimos J.,Armuzzi Alessandro,Sebastian Shaji,Lara Nuria,Lynam Mark,Rojas-Farreras Sonia,Fan Tao,Ding Qian,Black Christopher M.,Kachroo Sumesh

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Medical and surgical management of chronic ulcerative colitis;Cima;Archives of Surgery,2005

2. Immune dysfunction in inflammatory bowel disease;Neuman;Translational Research,2007

3. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012

4. Current approaches to the management of new-onset ulcerative colitis;Marchioni Beery;Clinical and Experimental Gastroenterology,2014

5. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US;Cohen;Journal of Medical Economics,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial Piezo1 deletion ameliorates intestinal barrier damage by regulating ferroptosis in ulcerative colitis;Free Radical Biology and Medicine;2024-11

2. Efficacy and safety of the S1PR modulator etrasimod in the treatment of moderately to severely active ulcerative colitis during the induction phase: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Pharmacology;2024-09-09

3. Disease burden of patients with moderate to severe ulcerative colitis: A French multicenter real-life study (THEFAR);Digestive and Liver Disease;2024-09

4. Empirical Testing of Alternative Search Methods to Retrieve Utility Values for Health Economic Modelling;PharmacoEconomics;2024-08-06

5. Effectiveness and safety of vedolizumab and infliximab in biologic‐naïve patients with moderate‐to‐severe ulcerative colitis: A multicenter, retrospective cohort study;Journal of Digestive Diseases;2024-04